CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany
BackgroundEarly high-efficacy treatment for people with relapsing multiple sclerosis (pwRMS) may provide better long-term outcomes compared with the escalation strategy. In this study, we present an analysis of treatment success and safety from the CONFIDENCE study in a real-world cohort of pwRMS tr...
Saved in:
| Main Authors: | Mathias Buttmann, Martin S. Weber, Sven G. Meuth, Sandra Blümich, Stefanie Hieke-Schulz, Petra Dirks, Julius C. Eggebrecht, Tjalf Ziemssen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1564327/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review
by: D. L. Klabukova, et al.
Published: (2018-11-01) -
Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-11-01) -
Real-World Persistence with Ocrelizumab in Multiple Sclerosis: a Systematic Review
by: John L. Petrie, et al.
Published: (2024-10-01) -
Tryptophan pathway profiling in multiple sclerosis patients treated with ocrelizumab
by: Carolina Ricci, et al.
Published: (2025-06-01) -
Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab
by: Franz Felix Konen, et al.
Published: (2025-08-01)